title: Multiple restriction enzyme digests are required to rule out polymorphism in the molecular diagnosis of chronic myeloid leukemia.
authors.affiliation: Lifecodes Corporation, Valhalla, New York.
authors.forename: A
authors.initials: A
authors.lastname: Grossman
authors.forename: A
authors.initials: A
authors.lastname: Mathew
authors.forename: M P
authors.initials: MP
authors.lastname: O'Connell
authors.forename: P
authors.initials: P
authors.lastname: Tiso
authors.forename: A
authors.initials: A
authors.lastname: Distenfeld
authors.forename: P
authors.initials: P
authors.lastname: Benn
mesh_terms: D015139:Blotting, Southern; D004247:DNA / Q000032:analysis; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000235:genetics*; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins / Q000235:genetics; D051562:Proto-Oncogene Proteins c-bcr
chemical_list: D011518:Proto-Oncogene Proteins; D004247:DNA; D011505:Protein-Tyrosine Kinases; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr